William D. Johnston, PhD
Chief Executive Officer, InVasc Therapeutics, Inc., Georgia

Dr. William Johnston is CEO of InVasc Therapeutics, an early stage company focused on  cardiometabolic diseases.  Dr. Johnston has more than thirty years of executive experience in the biotechnology and medical industry.  From 1997 through 2006 he was President & CEO of Inhibitex, Inc., a public biopharmaceutical company.  From 1975 to 1997, Dr. Johnston held various executive positions at Baxter Healthcare Corporations including Vice President and General Manager of the Gene Therapy Business Unit and Vice President of Applied Sciences, the central research and development unit of Baxter.  Dr. Johnston has served on the board of the Georgia Biomedical Partnership since 1999, and is currently a member of the executive committee; he also served as chairman for the bioscience council executive committee for the Metro Atlanta Chamber of Commerce, and is currently an advisory member for the Georgia Department of Economic Development and the advisory committee for Georgia State University.  He is a member of the board of trustees for the Emory Johns Creek Hospital.  In the recent past, Dr. Johnston served on the board of directors and on the Healthcare and Emerging Companies Section Governing Bodies of the Biotechnology Industry Organization.  In the past has been an advisory committee for Northwestern University Department of Chemical Engineering, and the University of Illinois College of Engineering.  His B.S. in Chemistry and Ph.D. in organic chemistry were earned at Brigham Young University.